Wind Stocks Trading Alert; Clean Wind Energy Tower, Inc. (OTCBB: CWET) Up on Patent News

Point Roberts, WA � March 7, 2011 - Investorideas.com, a leader in cleantech stock research, releases a trading alert for Clean Wind Energy Tower, Inc. (OTCBB:CWET). The stock is trading at $0.25, up 0.05 (25.00%) on patent news.
The Company announced today it had filed with the United States Patent & Trademark Office "A Petition to Make Special Under Accelerated Examination Program," a patent application titled Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as providing a consistency of power output during deviations in wind speed.
News: http://www.investorideas.com/CO/CWE/news/2011/03071.asp

Clean Wind Energy Tower, Inc. (OTCBB:CWET) www.cleanwindenergytower.com
Clean Wind Energy, Inc. a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large “Downdraft Towers” that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity.
Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.

Dual Renewable Energy Technology
The Downdraft Tower is a hollow cylinder with a water spray system at the top. Pumps deliver water to the top of the Downdraft Tower to spray a fine mist across the entire opening. The water evaporates and cools the hot dry air at the top. The cooled air is more dense and heavier than the outside warmer air and falls through the cylinder at speeds up to 50 mph, driving the turbines located at the base of the structure. The turbines are attached to generators to produce electricity. The exterior of the Downdraft Tower is constructed with vertical “wind vanes” that run the entire length of the structure. The Downdraft Tower's vanes capture the prevailing wind and channel it through a separate system of tunnels to turn turbines attached to generators that produce additional electrical power. This dual renewable energy resource enhances the capability and productivity of the Clean Wind system.
Environmental
Various parties in the United States and other nations are pursuing clean energy solutions that use efficient and cost- effective renewable resources to serve society while avoiding the adverse effects associated with fossil and nuclear fuels, and also the obvious limitations of solar collectors that work only when the sun shines or wind turbines that work only when the wind blows.
The Downdraft Tower has the capability of being operated with virtually no carbon footprint, fuel consumption, or waste production and this technology has the potential to generate clean, cost effective and efficient electrical power without the damaging effects caused by using fossil or nuclear fuels, and other conventional power sources. The Company also believes that increasing emphasis on green technologies and governmental incentives in the energy industry should have a positive long-term effect on the Company's planned business and the wind energy industry in general.
Partners
The Company has entered into a number of agreements with potential partners to meet the development aspects of the tower. Specifically, three of the largest companies in the world are working with clean wind providing final bids to meet the tower's specifications.
Visit the showcase page at Investorideas.com: http://www.investorideas.com/CO/CWE/
Contact the company:
410-972-4713
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on Clean Wind Energy,
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 shares 144) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. This site is currently compensated by featured companies, news submissions and online advertising. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information about Investorideas.com green stocks contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com

Wind Stocks; Clean Wind Energy Tower, Inc. (OTCBB: CWET) Files Unique Hydraulic System Patent

ANNAPOLIS, MD - March 7, 2011 (InvestorIdeas.com Newswire) - Clean Wind Energy Tower, Inc. (OTCBB: CWET) announced that the Company had filed with the United States Patent & Trademark Office "A Petition to Make Special Under Accelerated Examination Program," a patent application titled Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as providing a consistency of power output during deviations in wind speed.

John W. Hanback, Chief Technology Officer of CWET, stated, "We are extremely excited and positive about the application we submitted to the USPTO on February 25, 2011. As required our patent council diligently and extensively searched multiple patent data bases and resources as needed to present a comprehensive analysis as a basis for the patent examiners own due diligence and review. The technological concepts and applications claimed and embodied within this patent provide significant benefits toward enhancing the overall efficient power generation we will be providing our customers. We will continue to file multiple patent applications that are being readied, of which provisional patent applications already exist, under this beneficial accelerated review protocol."
Ronald W. Pickett, President and CEO of CWET, stated, "Clean Wind Energy Tower, Inc. continues to cultivate innovative technological imperatives in addition to our already advanced wind energy structural designs and enhanced power generation methodologies. We applaud the USPTO and our Government for waiving the petition filing fee, for cases based on critical claimed subject matter directed to energy, among other categories, within this accelerated format. To reiterate our CTO's statement, this application is but the first of many that we will file, focused on our leadership and value proposition for producing clean renewable fuel resources."
About Clean Wind Energy, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large "Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.
Statements included in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Contact
Clean Wind Energy, Inc.
1997 Annapolis Exchange Parkway Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
www.cleanwindenergytower.com

Visit the CWET showcase profile at Investorideas.com
Request News and Info on CWET
Disclosure, Disclaimer/ CWET is a paid advertising client on Investorideas.com and our Renewable Energy portals. (one thousand five hundred, 100,000 144 shares)

Mining Stocks; YALE (TSX-V: YLL) Stakes Additional Land at Los Amoles � Samples 432 g/t Silver Over 2.2 M

March 7, 2011 (Investorideas.com Mining stocks Newswire) - Yale Resources Ltd. (TSX-V: YLL and Frankfurt: YAB) is pleased to report it has applied for, by staking, an additional land adjoining the Los Amoles Property. Work at Los Amoles is being done by Yale on behalf of Sonora Resources Corp. (previously Nature's Call), who has an option to earn a 70% interest in the property.

This new land package is 1,960 hectares (19.6 square kilometres) in size and covers extensions of the known mineralizing system to the east and south of the main target area of the property.
Reconnaissance sampling aimed at evaluating the potential continuation of the greater than 800 metres of strike extension of the mineralization identified to date returned very encouraging values of:

• 50 cm grading 0.41 g/t gold and 215.6 g/t silver, and
• 2.20 m averaging 0.39 g/t gold and 432.0 g/t silver.

To date, greater than 45 historic workings and greater than 20 silver/gold veins have been identified within approximately 60% of the El Rosario target area that measures 1.0 by 2.5 kilometres. Additional fieldwork is planned to map and sample the remaining areas within the El Rosario target. This work will be done in advance of geophysics, which in turn, will be done to delineate priority locations for drilling.
About the Los Amoles Property:
The early stage wholly owned 16.3 square kilometre Los Amoles Property is located approximately 150 kilometres northeast of the Hermosillo, Sonora State, Mexico. The property is 10 kilometres northeast of the La Caridad Mine, operated by Grupo Mexico, which is one of the largest mining and processing complexes in Mexico.
Sonora Resources has an option to earn a 70% interest in the property by paying to Yale US $ 50,000 (received), spending US $ 900,000 on exploration expenditures and issuing 1,000,000 shares (200,000 have been received) to Yale over three years.
Samples from Los Amoles were prepared and analyzed by IPL Inspectorate in their facilities in Mexico and Vancouver, respectively. Samples generally consisted of 1-3 kg of material. Gold and silver analyses were performed by 30 gram fire assay with an AA finish. Samples with greater than 100 g/t silver were re-assayed using gravimetric methods.
Ian Foreman, P.Geo., is Yale Resources' Qualified Person, as defined by National Instrument 43-101. The Los Amoles property is an early stage project that requires additional sampling and geological mapping to fully determine the project's potential.
About Yale Resources:
Yale Resources is an exploration and development company concentrating in northwestern Mexico. Utilizing the joint venture business model, Yale is able to maximize its exposure to discovery while minimizing exploration risk. At the same time Yale continues to work on its non-optioned properties as well as reviewing new projects. Yale has four projects under option to value added partners with commitments for approximately $1.0M in expenditures during the next 12 months.
On behalf of the Board,
"Ian Foreman"
Ian Foreman, P.Geo.
President

For additional information on Yale Resources please call the Company at 604-678-2531.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.

Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.
Contact:
Yale Resources Ltd.
Ian Foreman
604-678-2531

Visit the YLL showcase profile at Investorideas.com
Request News and Info on YLL
Disclosure, Disclaimer/ YLL is a paid advertising client on Investorideas.com and our mining portals.

Energy Stocks News; American Petro-Hunter (OTCBB: AAPH) Announces Drilling Underway at NOS227 Well on North Oklahoma Oil Project

SCOTTSDALE, AZ � March 7, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is pleased to announce today that the NOS227 Well at the North Oklahoma Project located in Payne County, Oklahoma has spud and the well is drilling ahead.

It is anticipated that NOS227 will reach its planned depth of 4,000 feet in seven days. As previously reported, the primary objective is the productive Woodford and Mississippi Formations with secondary opportunities identified in the Miesner and Skinner Sands. The location exhibits the potential for 80 plus feet of pay from the known productive formations which offset to the northwest and southeast.
American Petro-Hunter is currently producing oil from the Woodford and the Mississippian at its No.1 and NOJ26 wells. The new NOS227 is a direct offset to the recently completed commercial oil well at the NOJ26 location and takes advantage of a favorable oil producing geological trend up dip and to the west offsetting existing production.
A successful Mississippian-Woodford well with comingled production from both formations is estimated to offer a 150-250 BPD potential. American Petro-Hunter has a 50% interest in the well.
Company President Robert McIntosh states, "The NOS227 location offers targets in the Mississippian and Woodford formations which are the current focus of all the considerable recent E&P excitement in Payne County. As the play in Northern Oklahoma unfolds throughout the year ahead, we anticipate announcements of big discovery wells from horizontal drilling in the area that rival some of the early Bakken Play results. The Company is strategically positioned with leases and locations that have prime Mississippian-Woodford access that will allow us to participate with drilling operations right in the heart of the play."
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com

Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)

NASDAQ Leaders; (NASDAQ: ATRN) Trading at 5.68, up 2.70 90.28%,

POINT ROBERTS, Wash., March 7, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on trading leaders on the NASDAQ. Direct-to-consumer company, Atrinsic, Inc. $ (NASDAQ: ATRN) is the top gainer, currently trading at 5.68, up 2.70 90.28% 875,217. Energy investors are also seeing strong gains in select stocks as oil trades above $105.

Trading Close-Up

Company Last Sale* Change Net / % Share Volume
Atrinsic, Inc. $ (NASDAQ: ATRN) trading at 5.68, up 2.70 90.28% 875,217

Synthesis Energy Systems, Inc. (NASDAQ: SYMX) trading at $ 2.04, up 0.68 50.00% 3,671,658

TomoTherapy Incorporated (NASDAQ: TOMO) trading at $ 4.56, up 0.89 24.25% 12,219,581

RAM Energy Resources, Inc. (NASDAQ: RAME) trading at $ 2.44, up 0.42 20.79% 11,249,507

Market Snapshot (at time of release)

Dow 12,067.37 -102.51 -0.84%

Nasdaq 2,736.10 -48.57 -1.74%

S&P 500 1,307.39 -13.76 -1.04%

10 Yr Bond (%) 3.5010% +0.0090

Oil 105.37 +0.95 +0.91%

Company Snapshot- (NASDAQ:ATRN)

Atrinsic, Inc. is a marketer of direct-to-consumer subscription products and an Internet search-marketing agency. Atrinsic sells entertainment and lifestyle subscription products directly to consumers, which are marketed through the Internet. Atrinsic also sells Internet marketing services to its corporate and advertising clients. Atrinsic has developed its marketing media network, consisting of web sites, proprietary content and licensed media, to attract consumers, corporate partners and advertisers. Atrinsic believes its marketing media network and proprietary technology allow it to cost-effectively acquire consumers for its products and for its corporate partners and advertisers.


Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Research energy stocks, mining, agriculture stocks, cloud computing stocks and more…

Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/

About InvestorIdeas.com:

Investor Ideas is a global financial media online destination specialized in sector investing content. Investor Ideas (and portals within the hub) was one of the first online investing and business resources providing in-depth information, news and stock directories in renewable energy, homeland security and water sectors. InvestorIdeas.com features over twenty industry sectors and global markets including China, India, Middle East and Australia.

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp

For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com

Source – Investorideas.com

Oil and Gas Stocks Directory Grows to over 700 Stocks; Includes Bakken Stocks, Woodford Shale and Oil Sands Stocks

POINT ROBERTS, Wash. - March 4, 2011 - www.InvestorIdeas.com, a leader in sector research for investors, including energy stocks, updates the oil and gas stocks directory for March, now listing over 700 publicly traded oil and gas stocks. As oil continues to rise, hitting $103. the energy stocks directory is one of the most visited pages at Investorideas.com.
The oil and gas stocks directory features over seven hundred stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. The directory also features a section on Bakken stocks and oil sands stocks.
Preview the directory here: http://www.investorideas.com/OGSN/Stock_List.asp
Featured Energy Stock:
American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the hunt for domestic petroleum assets. www.americanpetrohunter.com
Company Research
http://www.aaphreport.com/
Visit the AAPH showcase profile at Investorideas.com
http://www.investorideas.com/CO/AAPH/
Request News and Info on AAPH
http://www.investorideas.com/Resources/Newsletter.asp
Contact American Petro-Hunter:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com

Investorideas.com energy stock directories for investors:

Oil and Gas Stocks Directory - Global Oil and Gas Stocks Directory of Publicly traded oil and gas stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the energy sector. The directory in PDF format, features hyperlinks to over 600 stocks symbol(s), company's URL and company's description.
Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China and other leading global Stock Exchanges . The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the coal sector, including clean coal and coking coal stocks. The directory in PDF format, features hyperlinks to coal stocks symbol(s), company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for review. Natural gas stocks included range from LNG, Coal Bed Methane to exploration and producers in the sector. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description.
Renewable Energy Stocks Directory - Global Green and Renewable Energy Stocks Directory in PDF format includes over 1200 stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges . The directory features hyperlinks to stocks symbol(s), company’s URL and company’s description. The directory includes info and links on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency Stocks, Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen Production, Micro Turbine Stocks, Solar Stocks, Smart Grid Stocks, Green Transportation, Wind Power and Wind Energy Stocks and Green Infrastructure Stocks. For investors following green stocks, this is the most comprehensive global stock directory online.
Investorideas.com members can access all energy stock directories, in addition to biotech, nanotech, water, defense and the newly added tech stocks for cloud computing and social network stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content.
Disclosure: American Petro-Hunter, Inc. (OTC.BB: AAPH) is a paid advertising showcase company on Investorideas.com ( two thousand per month blended average)
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com

Agriculture Stocks Directory added to Investor Ideas Members Content

POINT ROBERTS, Wash., March 4, 2011 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research, is pleased to report to recent additions to the Investor Ideas member content includes the agriculture stocks directory and the new tech stocks directory featuring cloud computing and social media stocks.

The agriculture stocks directory has been one of the most visited pages on the site for several months as global food concerns and prices rise.
Preview the agriculture stocks directory: http://www.investorideas.com/MSS/Arg_Stock_List.asp
Investor Ideas membership currently features eleven stock directories, including one of the largest green and renewable energy stocks directory online, featuring over 1200 green publicly traded companies .
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Additional stock directories at Investorideas.com for investors:
Renewable Energy Stocks Directory - Global Green and Renewable Energy Stocks Directory in PDF format includes over 1200 stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges . The directory features hyperlinks to stocks symbol(s), company’s URL and company’s description. The directory includes info and links on Alternative Energy Funds, Biogas and Ethanol Stocks, Energy Efficiency Stocks, Flywheel Stocks, Fuel Cell Stocks, Geothermal Stocks, Hydrogen Production, Micro Turbine Stocks, Solar Stocks, Smart Grid Stocks, Green Transportation, Wind Power and Wind Energy Stocks and Green Infrastructure Stocks. For investors following green stocks, this is the most comprehensive global stock directory online.
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1100 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to stocks symbol(s), company’s URL and company’s description.
Oil and Gas Stocks Directory - Global Oil and Gas Stocks Directory of Publicly traded oil and gas stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the energy sector. The directory in PDF format, features hyperlinks to over 600 stocks symbol(s), company's URL and company's description.
Coal Stocks Directory - Global Directory of Publicly traded Coal stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, China and other leading global Stock Exchanges . The comprehensive directory gives investors a full range and choice of micro cap to large cap stocks in the coal sector, including clean coal and coking coal stocks. The directory in PDF format, features hyperlinks to coal stocks symbol(s), company's URL and company's description.
Defense Stocks Directory - Global Defense and Homeland Security Stocks Directory features publicly traded defense stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory, in PDF format, includes Homeland Security Stocks, Aerospace and Defense Stocks, Biodefense Stocks, Security Stocks, Energy Security Stocks and Infrastructure Stocks with hyperlinks to stocks symbol(s), company's URL and company's description. For defense stocks followers, this is one of the most comprehensive global stock directories available to investors.
Water Stocks Directory - Global Water Stocks Directory of publicly traded water stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The stock directory features water stocks ranging from desalination companies to bottled water stocks, to infrastructure, water treatment and technology as well as other sub sectors. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description. For investors following water stocks this is one of the most comprehensive directories in the sector available.
Environment Stocks Directory - Global Green Stocks Directory of Publicly traded Environmental Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description.
Fuel Cell Stocks Directory - Global Directory of Publicly traded Fuel Cell Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for review. For green investors looking for opportunities in the fuel cell sector, the comprehensive global directory in PDF format provides a great research tool with hyperlinks to stocks symbol(s), company's URL and company's description.
Biotech Stocks Directory - Global Directory of Publicly Traded Biotech,Pharma and Life Sciences Stocks ,on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges . The directory covers all sub sectors of biotech including nanotech, biodefense and stem cell stocks. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for investors The comprehensive global directory in PDF format provides a great research tool for biotechnology investors with hyperlinks to stocks symbol(s), company's URL and company's description.
Natural Gas Stocks Directory - Global Directory of Publicly traded Natural Gas Stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading global Stock Exchanges. The directory includes small cap, micro cap as well as large cap NYSE listed stocks for review. Natural gas stocks included range from LNG, Coal Bed Methane to exploration and producers in the sector. The directory in PDF format, features hyperlinks to stocks symbol(s), company's URL and company's description.
Nanotechnology Stocks Directory - Investorideas.com global stock directory of publicly traded nanotech stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, Hong Kong and China and other leading Stock Exchanges. Directory includes nanotech- biotech companies, nanotech water and renewable energy companies and more. Directory features company description, stock symbol and hyperlink to recent quote and info, link to website and more.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com

Biotech/Pharma Stock News; BioSante Pharmaceuticals (NASDAQ: BPAX) to Raise $25.1 Million in Registered Direct Offering

LINCOLNSHIRE, Ill. - March 4, 2011 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that it has received commitments from several institutional investors to purchase $25.1 million of securities in a registered direct offering. BioSante expects to receive net proceeds of approximately $23.8 million after deducting placement agent fees and other offering expenses. BioSante has entered into securities purchase agreements with these investors pursuant to which BioSante has agreed to sell an aggregate of approximately 12.2 million shares of its common stock and warrants to purchase up to approximately 4.0 million additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.33 of a share of common stock, will be sold for a purchase price of $2.0613, a premium to the closing price on the day before pricing.

"We are pleased to have this commitment from these new and existing institutional investors," said Stephen M. Simes, BioSante's president and chief executive officer. "This additional funding provides us with added financial power to continue to fund our ongoing LibiGel� Phase III clinical study program. We recently announced completion of enrollment in the first of the two LibiGel Phase III efficacy trials and expect to announce completion of enrollment in the second in the near future. LibiGel remains the lead pharmaceutical product in the U.S. in active development for the treatment of hypoactive sexual desire disorder (HSDD) in menopausal women, and we continue to believe that LibiGel has the potential to be the first product approved by the FDA for this common and unmet medical need."
The warrants to purchase additional shares will be exercisable at an exercise price of $2.25 per share beginning immediately and will expire three years from their date of issuance. All of the securities were offered pursuant to an effective shelf registration statement. Proceeds from the transaction will be used for general corporate purposes, including continuing to fund BioSante's LibiGel Phase III clinical study program. The offering is expected to be consummated by March 8, 2011, subject to customary closing conditions.
Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., (NASDAQ:RODM), acted as the exclusive placement agent for the transaction. Oppenheimer & Co. Inc., Roth Capital Partners, LLC, JMP Securities LLC and Trout Capital, LLC acted as financial advisors.
Shelf registration statements relating to the shares of common stock and warrants issued in the offering (and the shares of common stock issuable upon exercise of the warrants) have been filed with the Securities and Exchange Commission (the "SEC") and declared effective. A prospectus supplement relating to the offering will be filed by BioSante with the SEC. Copies of the prospectus supplement and accompanying prospectuses may be obtained directly from BioSante by contacting BioSante Pharmaceuticals, Inc., 111 Barclay Boulevard, Lincolnshire, Illinois 60069. Copies of the final prospectus supplement and accompanying prospectuses relating to the offering also may be obtained from Rodman & Renshaw, LLC, 1251 Avenue of the Americas 20th Floor, New York, NY 10020 or by calling (212) 356-0549. This announcement is neither an offer to sell nor a solicitation of an offer to buy any shares of common stock or warrants of BioSante. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may," other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com

Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).

Biotech/Pharma Stock Trading Alert; BioSante Pharmaceuticals Inc (NASDAQ:BPAX) up over 10% on News

Point Roberts, WA. - March 3, 2011 (Investorideas.com Energy stocks Newswire) - www.InvestorIdeas.com, a leader in sector stock research including biotech stocks, releases a technical stock trading alert for BioSante Pharmaceuticals Inc (NASDAQ:BPAX). The stock is currently trading at $2.27, up 0.23 (11.82%), trading as high as $2.52 in morning trading.
The stock traded up on news headline "BioSante's (NASDAQ: BPAX) Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study."
BPAX Stock Chart
Today's News:
Biotech/Pharma Stock News; BioSante's (NASDAQ: BPAX) Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study

"LINCOLNSHIRE, Ill. - March 3, 2011 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced publication of results from a Phase II clinical study that show BioSante's Pancreas Cancer Vaccine increased the median survival of resected pancreatic cancer patients from 15 to 20 months, as reported in published data, to 24.8 months, an increase of more than 25 percent. In addition, the vaccine demonstrated a 35 percent increase in one year survival, from 63 percent to 85 percent. A new multicenter clinical study is planned to begin this year.
In the study, titled, "A Lethally Irradiated Allogeneic GM-CSF-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation," published in the February 2011 issue of Annals of Surgery, the primary endpoint was disease free survival and secondary endpoints were overall survival and toxicity, and the induction of mesothelin specific T cell responses. The median disease-free survival of patients was 17.3 months (95% CI, 14.6–22.8) with median survival of 24.8 months (95% CI, 21.2–31.6). The administration of immunotherapy was well tolerated. In addition, the postimmunotherapy induction of mesothelin-specific T cells in patients correlates with disease-free survival. The investigators concluded that "an immunotherapy approach integrated with chemoradiation is safe and effective for resected pancreas cancer."
The 60 patient Phase II study was conducted by researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland. The research was funded by the National Institutes of Health and other foundations. BioSante's Pancreas Cancer Vaccine is made from allogeneic pancreatic cancer cells genetically altered to produce an immune system stimulator called GM-CSF, and irradiated to prevent cell growth. BioSante already has received Orphan Drug designation from the U.S. Food & Drug Administration for the Pancreas Cancer Vaccine.”
Full News at: http://www.investorideas.com/CO/BPAX/news/2011/03031.asp
More info: About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About our Biotech investor portal : www.biotechindustrystocks.com
BiotechIndustryStocks.com is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Contact BioSante Pharmaceuticals
For Media:
McKinney/Chicago
Alan Zachary
(312) 506-5220; azachary@mckinneychicago.com
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953; tswanson@troutgroup.com
Investorideas.com Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com. (one thousand per month)
Disclaimer: The following news is paid for by BPAX (one thousand per month) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com to become a biotech showcase stock or research biotech stocks
800 665 0411 cvanzant@investorideas.com

Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).

Biotech/Pharma Stock Trading Alert; BioSante Pharmaceuticals Inc (NASDAQ:BPAX) up over 10% on News

Point Roberts, WA. - March 3, 2011 (Investorideas.com Energy stocks Newswire) - www.InvestorIdeas.com, a leader in sector stock research including biotech stocks, releases a technical stock trading alert for BioSante Pharmaceuticals Inc (NASDAQ:BPAX). The stock is currently trading at $2.27, up 0.23 (11.82%), trading as high as $2.52 in morning trading.
The stock traded up on news headline "BioSante's (NASDAQ: BPAX) Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study."
BPAX Stock Chart
Today's News:
Biotech/Pharma Stock News; BioSante's (NASDAQ: BPAX) Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study

"LINCOLNSHIRE, Ill. - March 3, 2011 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced publication of results from a Phase II clinical study that show BioSante's Pancreas Cancer Vaccine increased the median survival of resected pancreatic cancer patients from 15 to 20 months, as reported in published data, to 24.8 months, an increase of more than 25 percent. In addition, the vaccine demonstrated a 35 percent increase in one year survival, from 63 percent to 85 percent. A new multicenter clinical study is planned to begin this year.
In the study, titled, "A Lethally Irradiated Allogeneic GM-CSF-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation," published in the February 2011 issue of Annals of Surgery, the primary endpoint was disease free survival and secondary endpoints were overall survival and toxicity, and the induction of mesothelin specific T cell responses. The median disease-free survival of patients was 17.3 months (95% CI, 14.6–22.8) with median survival of 24.8 months (95% CI, 21.2–31.6). The administration of immunotherapy was well tolerated. In addition, the postimmunotherapy induction of mesothelin-specific T cells in patients correlates with disease-free survival. The investigators concluded that "an immunotherapy approach integrated with chemoradiation is safe and effective for resected pancreas cancer."
The 60 patient Phase II study was conducted by researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland. The research was funded by the National Institutes of Health and other foundations. BioSante's Pancreas Cancer Vaccine is made from allogeneic pancreatic cancer cells genetically altered to produce an immune system stimulator called GM-CSF, and irradiated to prevent cell growth. BioSante already has received Orphan Drug designation from the U.S. Food & Drug Administration for the Pancreas Cancer Vaccine.”
Full News at: http://www.investorideas.com/CO/BPAX/news/2011/03031.asp
More info: About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About our Biotech investor portal : www.biotechindustrystocks.com
BiotechIndustryStocks.com is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Contact BioSante Pharmaceuticals
For Media:
McKinney/Chicago
Alan Zachary
(312) 506-5220; azachary@mckinneychicago.com
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953; tswanson@troutgroup.com
Investorideas.com Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com. (one thousand per month)
Disclaimer: The following news is paid for by BPAX (one thousand per month) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp 
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp 
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com to become a biotech showcase stock or research biotech stocks
800 665 0411 cvanzant@investorideas.com

Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).

Oil and Gas Stocks Trading Alert; Aroway Energy Inc. (TSX.V: ARW) Trading up 14.93 % on News

Point Roberts, WA - March 3, 2011 (Investorideas.com Newswire) - www.InvestorIdeas.com, a leader in sector research including energy stocks, releases a technical stock trading alert and stock chart for energy stock Aroway Energy Inc. (TSX.V: ARW). The stock at the time of the release is trading at$ 0.385, up 0.05 (14.93%) on 123,530 shares. The company reported news today their 20111 drilling program has commenced. The stock has traded as high as $0.41.
Trading stock chart March 3
News:
Oil and Gas Stocks; Aroway Energy Inc. (TSX-V: ARW; PINK: ARWJF) Begins 2011 Drill Program
"CALGARY, ALBERTA - March 3, 2011 (Investorideas.com energy stocks newswire) - Aroway Minerals Inc. (TSX-V:ARW; PINK:ARWJF) (www.arowayenergy.com) (the "Company") is pleased to announce that the Company has begun drilling operations on its first well of the Company's 2011 Peace River Arch exploration drilling program. The 3D seismically defined multi-zone prospective well is located on the newly acquired lands announced by the Company on February 14, 2011. The well is targeting the Leduc formation at a depth of approximately 2,300 meters. The drilling operations of this well are being operated by the Company's joint venture farm in partner with the Company paying 50% of all costs associated with this well to earn a 50% interest in the well. This exploration well is expected to take approximately 17 days to reach total depth."
Full Article: http://www.investorideas.com/CO/ARW/news/2011/03031.asp
About Aroway Energy Inc.:

Aroway Energy Inc. is junior oil and gas exploration Company focused on high working interest non-operated oil and gas exploration prospects. Aroway is currently participating in two exploration wells which are programmed to a total depth into the Leduc formation in the Peace River Arch area of Alberta. The Company will pay 75% of all costs to earn 50% of all revenues in the exploration program.
Contact Aroway Energy Inc
Judy-Ann Pottinger
Aroway Energy Inc.
(604) 304-4090 or Cell: (604) 617-5290
(604) 909-2679 (FAX)
jpottinger@arowayenergy.com
www.arowayenergy.com
(647) 258-3311 or Toll Free: (888) 258-3323
Investor Cubed Inc.
(416) 363-7977 (FAX)
info@investor3.ca
Visit the company's showcase page at http://www.investorideas.com/CO/ARW/
Visit the Company's website at
www.arowayenergy.com
About Investor Ideas Oil and Gas portal:
OilandGasStocksNews.com is a global meeting place for investors and industry following the energy sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our oil and gas and natural gas stock directories.
Research more oil and gas stocks :
http://www.investorideas.com/OGSN/Stock_List.asp
Disclaimer: The following Aroway Energy Inc news is paid for on behalf of ARW ($2000) per month. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp 
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp 
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Disclosure: ARW is a paid advertising client on Investorideas.com and our energy, natural gas, and oil and gas portals.

Visit the ARW showcase profile at Investorideas.com
Request News and Info on ARW

Investor Alert for Lithium/ Battery Stock Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF)

Point Roberts, WA - March 3, 2010 - Investorideas.com, a leader in sector research including mining and cleantech stocks, releases recent news and commentary on Lomiko Metals Inc. ( TSX-V:LMR , OTC: LMRMF).

Lomiko's (TSX-V: LMR , OTC: LMRMF) corporate objective, through the acquisition and exploration of high quality mineral mining projects and development, is to become a fully integrated battery supplier. Lomiko is currently exploring for salt brines that contain lithium, sodium, sulfate, chloride and potash in salt lakes or salars.
The following alert hi-lights recent press releases and research report, CFA commentary from Sustainable Kapital.
nvestorideas.com features research from leading and recognized third party independent research firms, as part of the overall due diligence and research tools available to individual investors.
Recent News:
LOMIKO METALS INC. ANNOUNCES $400,000 FLOW-THROUGH PRIVATE
PLACEMENT FINANCING
"Vancouver, BC. - LOMIKO METALS INC. (TSX-V: LMR, OTC: LMRMF, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7,) ("Lomiko" or "the Company) announces a private placement to raise up to $400,000 through the sale of up to 5,000,000 flow-through units of the Company priced at $0.08 per unit. Each flow-through unit will consist of 1 flow-through common share and one half of one transferable non-flow-through share purchase warrant, each full warrant being exercisable at a price of $0.12 for a period of 12 months after the closing date. The Company has agreed to pay a cash commission of 5% and finder's fee options equal to 8% of the number of units subscribed for at the unit price of $0.08 for a term of 12 months, with each unit consisting of a common share and a half warrant on the same terms as the unit half warrant stated above."
Full News: http://www.lomiko.com/public/files/news/LMR%20NR%20$400000%20FLOW-THROUGH%20UNITS%20_final_%2002-17-2011%20_2_.pdf
Report Excerpt:
Sustainable Kapital initiates coverage of Lomiko Metals Inc. (TSX.V: LMR)
February 25, 2011 --
Sustainable Kapital is initiating coverage of Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7,) with its February 9, 2011 report "Lomiko Metals Inc- A LITHIUM AND GOLD COMPANY". The full report is now at http://sustainablekapital.com/reports/wp-content/uploads/2011/02/LMR_Report_b.pdf
The company is listed on the Venture Exchange in Canada, Frankfurt, and the OTC in the USA.
"Interest in Northern B.C. by Chinese firms is steadily growing and the Cassiar Gold District is a location with the geology, infrastructure and potential to see significant development and mining activity.", states Sabrina Tsai, Analyst.
The Lomiko report will be updated on a regular basis as developments warrant and includes information on the Lithium and Soda Ash markets. The report describes the three projects that the Company is pursuing:

• Vines Lake, which is contiguous to Hawthorne Gold Corporation (a firm to be renamed China Mineral Holding after a major investment from China is approved by the TSX.)
• Karolina Lithium Property, which consists of 8 claims in Salar Aguas de Calientes adjacent to SQM, which is the world's largest producer of Lithium with production mostly coming from Salar de Atacama
• Rose Lake and Cunningham Lake Soda Ash (Sodium Carbonate) properties in BC, and are located near past producing lakes, which produced an estimated 900 tonnes of sodium carbonate.

About Sustainable Kapital: Sustainable Kapital is a division of Sustainable Capital Corporation, which provides capital markets advisory services for public companies as well as companies looking to go public. Its team includes financial analysts, and CFOs who assist firms who require an increased visibility with retail or institutional investors. "
Read the full research report:
http://sustainablekapital.com/reports/wp-content/uploads/2011/02/LMR_Report_b.pdf
About Lomiko:
Lomiko Metals Inc. is a Canadian-based junior company whose objective is to increase shareholder value through the acquisition and exploration of high quality mineral mining projects and development into a fully integrated battery supplier. Lomiko is currently exploring for salt brines that contain lithium, sodium, sulfate, chloride and potash in salt lakes or salars. Lomiko's growth strategy is to become a fully integrated supplier of lithium ion batteries. The potential for partnership in creating lithium rechargeable batteries to replace current polluting methods of energy is excellent. Interest in lithium and lithium batteries is growing exponentially. The Company is committed to its development program and in showing corporate social and environmental stewardship in the arena.
Disclaimer/disclosure: The following Lomiko Metals news release is paid for by third party on behalf of LMR.V ($250 per news release /2 releases). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news release and profile submissions and online advertising. All information on public companies published is obtained from the company or public filings and materials.
The Lomiko Metals research report is the content and opinion of Sustainable Kapital
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com
Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Contact investorideas.com to distribute your news and profiles
800 665 0411
cvanzant@investorideas.com
Source - Investorideas.com, Sustainable Kapital, Lomiko Metals

Oil and Gas Stocks; Aroway Energy Inc. (TSX-V:ARW; PINK:ARWJF) Begins 2011 Drill Program

CALGARY, ALBERTA - March 3, 2011 (Investorideas.com energy stocks newswire) – Aroway Minerals Inc. (TSX-V:ARW; PINK:ARWJF) (www.arowayenergy.com) (the "Company") is pleased to announce that the Company has begun drilling operations on its first well of the Company's 2011 Peace River Arch exploration drilling program. The 3D seismically defined multi-zone prospective well is located on the newly acquired lands announced by the Company on February 14, 2011. The well is targeting the Leduc formation at a depth of approximately 2,300 meters. The drilling operations of this well are being operated by the Company's joint venture farm in partner with the Company paying 50% of all costs associated with this well to earn a 50% interest in the well. This exploration well is expected to take approximately 17 days to reach total depth.

This is the first of a possible six wells planned for the 2011 drill program. All of the planned exploration and / or development wells to be drilled are defined by seismic, have multi-zone prospectivety, and are close to infrastructure.
About Aroway Energy Inc.
Aroway Energy Inc. is a Western Canadian junior oil and gas production and exploration company participating in "non-operated" Peace River Arch oil and gas exploration prospects, through a joint venture partnership. Aroway is currently producing approximately 225 boe/day of oil, gas liquids and gas net to Aroway
ON BEHALF OF AROWAY ENERGY INC.
Chris Cooper, President
BOEs may be misleading, particularly if used in isolation. A BOE conversion ratio of 6 Mcf: 1bbl is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
Judy-Ann Pottinger
Aroway Energy Inc.
(604) 304-4090 or Cell: (604) 617-5290
(604) 909-2679 (FAX)
jpottinger@arowayenergy.com
www.arowayenergy.com
(647) 258-3311 or Toll Free: (888) 258-3323
Investor Cubed Inc.
(416) 363-7977 (FAX)
info@investor3.ca
Disclosure: ARW is a paid advertising client on Investorideas.com and our energy, natural gas, and oil and gas portals.

Visit the ARW showcase profile at Investorideas.com
Request News and Info on ARW

Investor Alert for Lithium/ Battery Stock Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF)

“Lomiko’s growth strategy is to become a fully integrated supplier of lithium ion batteries”

Point Roberts, WA – March 3, 2010 - Investorideas.com, a leader in sector research including mining and cleantech stocks, releases recent news and commentary on Lomiko Metals Inc. (TSX-V:LMR, OTC: LMRMF).
Lomiko’s (TSX-V: LMR, OTC: LMRMF) corporate objective, through the acquisition and exploration of high quality mineral mining projects and development, is to become a fully integrated battery supplier. Lomiko is currently exploring for salt brines that contain lithium, sodium, sulfate, chloride and potash in salt lakes or salars.

The following alert hi-lights recent press releases and research report, CFA commentary from Sustainable Kapital.


Investorideas.com features research from leading and recognized third party independent research firms, as part of the overall due diligence and research tools available to individual investors.
Recent News:



LOMIKO METALS INC. ANNOUNCES $400,000 FLOW-THROUGH PRIVATE

PLACEMENT FINANCING

“Vancouver, BC. - LOMIKO METALS INC. (TSX-V: LMR, OTC: LMRMF, Europe: ISIN:

CA54163Q1028, WKN: A0Q9W7,) (“Lomiko” or “the Company) announces a private placement

to raise up to $400,000 through the sale of up to 5,000,000 flow-through units of the Company

priced at $0.08 per unit. Each flow-through unit will consist of 1 flow-through common share

and one half of one transferable non-flow-through share purchase warrant, each full warrant

being exercisable at a price of $0.12 for a period of 12 months after the closing date.

The Company has agreed to pay a cash commission of 5% and finder’s fee options equal to 8%

of the number of units subscribed for at the unit price of $0.08 for a term of 12 months, with each unit consisting of a common share and a half warrant on the same terms as the unit half warrant stated above.”

Full News: http://www.lomiko.com/public/files/news/LMR%20NR%20$400000%20FLOW-THROUGH%20UNITS%20_final_%2002-17-2011%20_2_.pdf

Report Excerpt:

Sustainable Kapital initiates coverage of Lomiko Metals Inc. (TSX.V: LMR)
February 25, 2011 --

Sustainable Kapital is initiating coverage of Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7,) with its February 9, 2011 report "Lomiko Metals Inc- A LITHIUM AND GOLD COMPANY”. The full report is now at http://sustainablekapital.com/reports/wp-content/uploads/2011/02/LMR_Report_b.pdf
The company is listed on the Venture Exchange in Canada, Frankfurt, and the OTC in the USA.

“Interest in Northern B.C. by Chinese firms is steadily growing and the Cassiar Gold District is a location with the geology, infrastructure and potential to see significant development and mining activity.”, states Sabrina Tsai, Analyst.

The Lomiko report will be updated on a regular basis as developments warrant and includes information on the Lithium and Soda Ash markets. The report describes the three projects that the Company is pursuing:

• Vines Lake, which is contiguous to Hawthorne Gold Corporation (a firm to be renamed China Mineral Holding after a major investment from China is approved by the TSX.)

• Karolina Lithium Property, which consists of 8 claims in Salar Aguas de Calientes adjacent to SQM, which is the world’s largest producer of Lithium with production mostly coming from Salar de Atacama

• Rose Lake and Cunningham Lake Soda Ash (Sodium Carbonate) properties in BC, and are located near past producing lakes, which produced an estimated 900 tonnes of sodium carbonate.



About Sustainable Kapital: Sustainable Kapital is a division of Sustainable Capital Corporation, which provides capital markets advisory services for public companies as well as companies looking to go public. Its team includes financial analysts, and CFOs who assist firms who require an increased visibility with retail or institutional investors. “

Read the full research report:

http://sustainablekapital.com/reports/wp-content/uploads/2011/02/LMR_Report_b.pdf


About Lomiko:
Lomiko Metals Inc. is a Canadian-based junior company whose objective is to increase shareholder value through the acquisition and exploration of high quality mineral mining projects and development into a fully integrated battery supplier. Lomiko is currently exploring for salt brines that contain lithium, sodium, sulfate, chloride and potash in salt lakes or salars. Lomiko's growth strategy is to become a fully integrated supplier of lithium ion batteries. The potential for partnership in creating lithium rechargeable batteries to replace current polluting methods of energy is excellent. Interest in lithium and lithium batteries is growing exponentially. The Company is committed to its development program and in showing corporate social and environmental stewardship in the arena.

Disclaimer/disclosure: The following Lomiko Metals news release is paid for by third party on behalf of LMR.V ($250 per news release /2 releases). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news release and profile submissions and online advertising. All information on public companies published is obtained from the company or public filings and materials.



The Lomiko Metals research report is the content and opinion of Sustainable Kapital
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp

Investorideas.com

Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

Contact investorideas.com to distribute your news and profiles

800 665 0411

cvanzant@investorideas.com
Source - Investorideas.com, Sustainable Kapital, Lomiko Metals

Biotech/Pharma Stock News; BioSante's (NASDAQ: BPAX) Pancreas Cancer Vaccine Shows Survival Increase in Newly Published Study

LINCOLNSHIRE, Ill. - March 3, 2011 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced publication of results from a Phase II clinical study that show BioSante�s Pancreas Cancer Vaccine increased the median survival of resected pancreatic cancer patients from 15 to 20 months, as reported in published data, to 24.8 months, an increase of more than 25 percent. In addition, the vaccine demonstrated a 35 percent increase in one year survival, from 63 percent to 85 percent. A new multicenter clinical study is planned to begin this year.

In the study, titled, "A Lethally Irradiated Allogeneic GM-CSF-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation," published in the February 2011 issue of Annals of Surgery, the primary endpoint was disease free survival and secondary endpoints were overall survival and toxicity, and the induction of mesothelin specific T cell responses. The median disease-free survival of patients was 17.3 months (95% CI, 14.6�22.8) with median survival of 24.8 months (95% CI, 21.2�31.6). The administration of immunotherapy was well tolerated. In addition, the postimmunotherapy induction of mesothelin-specific T cells in patients correlates with disease-free survival. The investigators concluded that "an immunotherapy approach integrated with chemoradiation is safe and effective for resected pancreas cancer."
The 60 patient Phase II study was conducted by researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland. The research was funded by the National Institutes of Health and other foundations. BioSante�s Pancreas Cancer Vaccine is made from allogeneic pancreatic cancer cells genetically altered to produce an immune system stimulator called GM-CSF, and irradiated to prevent cell growth. BioSante already has received Orphan Drug designation from the U.S. Food & Drug Administration for the Pancreas Cancer Vaccine
"We are very excited by the positive results of this study. This is encouraging news concerning potential treatment for a disease that can be so devastating for so many patients," said Stephen M. Simes, BioSante�s president & CEO. "Besides pancreatic cancer, Johns Hopkins researchers also are investigating the use of BioSante�s cancer vaccines for the treatment of several different forms of cancer, including leukemia, breast cancer and multiple myeloma. We look forward to continuing our collaboration with this well-respected research institute as further studies are conducted."
About Pancreatic Cancer
About 95 percent of pancreatic cancer is adenocarcinomas. Patients with pancreatic cancer have one of the poorest five-year survival rates of any form of cancer with median survival around three to six months. Pancreatic cancer is sometimes called a "silent killer" because it does not always cause noticeable symptoms and most symptoms are non-specific and varied. It is for this reason that pancreatic cancer often is not diagnosed until the disease is too advanced for current treatment options to be effective. Therefore, in view of the current poor patient prognosis, the need for novel and improved pancreatic cancer treatments is urgent.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may," other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com

Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).